Gut is a leading international journal in gastroenterology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. The journal has an authoritative global Editorial Board and a growing international readership.
Free: Editor's Choice
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
Objective: Eosinophilic oesophagitis (EoO) is a clinicopathological condition defined by proton pump inhibitor-refractory oesophageal symptoms combined with...
Top 10 articles
What's hot – see which articles have been most read in the past month
Refresh your skills
Use these case based online tutorials designed to simulate bedside teaching
Register here
Receive selected information relevant to your specialty interests and be the first to know when the latest issue is published.
Register for email alerts to
GUT >>
- Online First : Online First
- Current issue : Current issue
- Archive : Supplements | Topic collections | Gut tutorials | RSS
- About the journal : About the journal | Editorial board | Instructions for authors | Unlocked | Thank you to our reviewers | Most read articles | Events
- Submit a paper : Online submission site | Instructions for authors | Unlocked open access articles
- Subscribe : Subscribe to the journal | Prices | Email alerts
- Help : Contact us | Feedback form | Reprints | Permissions | Advertising
